- Meeting abstract
- Open Access
Association of interleukin - 18 gene polymorphism with susceptibility or protective effect to HTLV-1 infection
© Wagatsuma et al; licensee BioMed Central Ltd. 2011
- Published: 6 June 2011
- Promoter Region
- Gene Polymorphism
- Genotypic Frequency
- Infected Patient
- Polymorphic Site
Polymorphisms in promoter region of IL-18 genes have been studied in many chronic inflammatory and infectious disorders. For instance, the IL-18 -137 GG and -607CC polymorphisms have been associated with elevated expression of IL-18, which could contribute for the inflammatory process and favor the antiviral effects of this cytokine. In this study, we evaluated the IL-18 promoter region -137C/G and -607A/C polymorphisms in HTLV-infected patients exhibiting (HAM) or not (HAC) symptomatic disease and in healthy controls.
The promoter region polymorphic sites (-137C/G and -607A/C) were evaluated by polymerase chain reaction - sequence specific primers (PCR-SSP) analysis using peripheral blood DNA obtained from HAC (54), HAM (44) and healthy control (150) individuals. Proviral load of infected patients (HAC and HAM) was determined by real-time PCR.
The -607CC genotype was less frequent for HAC group (p=0.0501; OR=0.4890; CI=0.2480 to 0.9643), and infected patients (p=0.0232; OR=0.5207; CI=0.3033 to 0.8937) compared to healthy controls. The -607AC genotype was more frequent for HAC group (p=0.0387; OR=1.991; CI=1.043 to 3.801), and infected patients (p=0.0376; OR=1.757; CI=1.047 to 2.948) compared to healthy controls. No significant difference was observed for allelic and genotypic frequencies of the -137C/G among deferments groups. No significant difference was observed for allelic and genotypic frequencies of the -137C/G and -607A/C polymorphisms when correlated with proviral load.
The -607CC (high producer of IL-18) genotype exhibited protective effect against the infection, whereas the -607AC genotype conferred susceptibility to HTLV-1 infection.
Financial Support: FAPESP, CNPq, CTC/FUNDHERP and INCTC.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.